Aerosolized, Recombinant Alpha 1-Antitrypsin

DRUG2 trials

Sponsors

Baxalta now part of Shire

Conditions

Alpha1-antitrypsin Deficiency

Phase 1

Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency

CompletedNCT00157092

Baxalta now part of ShireAlpha1-antitrypsin Deficiency

Start: 2004-03-01End: 2004-10-14Updated: 2021-05-05

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

CompletedNCT00161707

Baxalta now part of ShireAlpha1-antitrypsin Deficiency

Start: 2003-01-07End: 2003-10-01Updated: 2021-05-05